Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 61.6 M62.1 M61.6 M59.9 M63.6 M64.5 M 249.6 M Research & development —————— — Operating income 38.4 M7.4 M-19.2 M-63.1 M12.6 M37.6 M -32.1 M Non-Operating Income, Total -4.4 M9.1 M-2.2 M-9.6 M-6 M-2.4 M -20.2 M Interest expense, net of interest capitalized 11.6 M12.8 M14.1 M14.5 M14.3 M14.2 M 57.1 M Non-Operating Income, excl. Interest Expenses -16 M-3.7 M-16.3 M-24.1 M-20.3 M-16.6 M -77.3 M Unusual income/expense —————— — Pretax income 25.7 M-5.7 M-29.1 M-88.3 M-2 M22.9 M -96.5 M Equity in earnings —————— — Taxes 7.6 M3.5 M7.9 M-5.5 M2.8 M7.7 M 12.9 M Non-controlling/minority interest —————— — After tax other income/expense 1 M1.8 M-3.1 M1.3 M300 K0 -1.5 M Net income before discontinued operations 18.1 M-9.2 M-37 M-82.8 M-4.8 M15.2 M -109.4 M Discontinued operations —————— — Net income 18.1 M-9.2 M-37 M-82.8 M-4.8 M15.2 M -109.4 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 18.1 M-9.2 M-37 M-82.8 M-4.8 M15.2 M -109.4 M Basic earnings per share (Basic EPS) 0.16-0.08-0.32-0.72-0.040.13 -0.95 Diluted earnings per share (Diluted EPS) 0.16-0.08-0.32-0.72-0.040.13 -0.95 Average basic shares outstanding 115 M115 M115 M115 M115 M115.1 M — Diluted shares outstanding 115 M115 M115 M115 M115 M115.1 M — EBITDA 45.2 M700 K1 M-57.9 M35.1 M54.1 M 32.3 M EBIT 31.3 M-14.4 M-14.6 M-73.8 M19.7 M38.3 M -30.4 M Cost of revenue 383 M431.6 M409.9 M421.9 M426.5 M455.3 M 1.71 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 13.9 M15.1 M15.6 M15.9 M15.4 M15.8 M 62.7 M